Director
ERA Sciences
With a focus on practical, risk-based adoption, Andy blends classical GxP discipline with modern probabilistic thinking. This unique approach allows life sciences companies to harness uncertainty effectively, safeguarding patient safety, product quality, and data integrity while accelerating digital transformation.
Currently, Andy is the driving force behind the development of Phanero, a pioneering GxP compliance management platform. Phanero is designed to streamline system inventories and automate the delivery of AI/ML model validation and documentation—turning complex compliance hurdles into streamlined, high-speed workflows.
Breakout #1: Embracing AI to Build a Better Operation and QMS
Wednesday, April 22, 2026
2:40 PM - 3:25 PM East Coast USA Time